Postmenopausal Breast Cancer, Aromatase Inhibitors, and Bone Health: What the Surgeon Should Know
Author:
Publisher
Springer Science and Business Media LLC
Subject
Surgery
Link
http://link.springer.com/content/pdf/10.1007/s00268-016-3555-5.pdf
Reference55 articles.
1. Artigalás O, Vanni T, Hutz MH, Ashton-Prolla P, Schwartz IV (2015) Influence of CYP19A1 polymorphisms on the treatment of breast cancer with aromatase inhibitors: a systematic review and meta-analysis. BMC Med 13(1):139. http://www.biomedcentral.com/1741-7015/13/139
2. Sacco K, Grech G (2015) Actionable pharmacogenetic markers for prediction and prognosis in breast cancer. EPMA J 6(1):15. http://www.epmajournal.com/content/6/1/15
3. Busolo DS, Woodgate RL (2014) Cancer prevention in Africa: a review of the literature. Glob Health Promot 22(2):31–39. http://www.ncbi.nlm.nih.gov/pubmed/25027971
4. Williams N, Harris LN (2014) The renaissance of endocrine therapy in breast cancer. Curr Opin Obstet Gynecol 26(1):41–47. http://www.ncbi.nlm.nih.gov/pubmed/24346127
5. Wardley AM (2008) Understanding the BIG results: insights from the BIG 1-98 trial analyses. Adv Ther 25:1257–1275
Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. CYP19A1 rs10046 Pharmacogenetics in Postmenopausal Breast Cancer Patients Treated with Aromatase Inhibitors: One-year Follow-up;Current Pharmaceutical Design;2020-12-30
2. Osteoporotic Fractures of the Spine, Hip, and Other Locations after Adjuvant Endocrine Therapy with Aromatase Inhibitors in Breast Cancer Patients: a Meta-analysis;Journal of Korean Medical Science;2020
3. Novel insights into the complex architecture of osteoporosis molecular genetics;Annals of the New York Academy of Sciences;2019-09-26
4. Breast Cancer and Immunosenescence;Handbook of Immunosenescence;2019
5. Pharmacogenetics of Aromatase Inhibitors in Endocrine Responsive Breast Cancer: Lessons Learnt from Tamoxifen and CYP2D6 Genotyping;Anti-Cancer Agents in Medicinal Chemistry;2018-01-16
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3